Int J Thyroidol.  2019 May;12(1):54-57. 10.11106/ijt.2019.12.1.54.

A Case Report: Total Parathyroidectomy with Autotransplantation for Secondary Hyperparathyroidism

• Kim SH
• Seo DH
• Hwang SD
• Kim JW

• KMID: 2449066
• DOI: http://doi.org/10.11106/ijt.2019.12.1.54

Abstract

Secondary hyperparathyroidism (HPT) usually result from parathyroid gland hyperplasia that produces excess parathyroid hormone (PTH). Decreased renal function leads to elevate serum phosphate levels and reduce vitamin D production, which results in hypocalcemia. Skeletal resistance to PTH results in persistently and frequently extremely elevated PTH levels and renal osteopathy. Treatment of choice for secondary HPT is medical management including calcitriol and vitamin D. However, for some cases in calciphylaxis and the failure including PTH >800 pg/mL or osteoporosis under maximal medical management surgical intervention could be an alternative option. We described a case of 47-year-old woman with surgical intervention for secondary hyperparathyroidism.

Keyword

Secondary hyperparathyroidism; Parathyroidectomy; Autotransplantation

MeSH Terms

Autografts*
Calciphylaxis
Calcitriol
Female
Humans
Hyperparathyroidism, Secondary*
Hyperplasia
Hypocalcemia
Middle Aged
Osteoporosis
Parathyroid Glands
Parathyroid Hormone
Parathyroidectomy*
Transplantation, Autologous*
Vitamin D
Calcitriol
Parathyroid Hormone
Vitamin D

Figure

• 

  Fig. 1 Parathyroid SPECT/CT (single-photon emission computed tomography/computed tomography) findings represent multiple increased MIBI (methoxyisobutyl-isonitrile) uptake (A), right superior (B), left inferior portion of thyroid gland (C).

• 

  Fig. 2 Round-shaped hyperplastic left inferior parathyroid in left level VI - paratracheal area (A), resected mass (B).

Reference

1. Jamal SA, Miller PD. Secondary and tertiary hyperparathyroidism. J Clin Densitom. 2013; 16(1):64–68.

2. Pitt SC, Sippel RS, Chen H. Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am. 2009; 89(5):1227–1239.

3. Grimelius L, Akerstrom G, Johansson H, Bergstrom R. Anatomy and histopathology of human parathyroid glands. Pathol Annu. 1981; 16(Pt 2):1–24.

4. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest. 1996; 97(11):2534–2540.

5. Parfitt AM. The hyperparathyroidism of chronic renal failure: A disorder of growth. Kidney Int. 1997; 52(1):3–9.

6. Stanbury SW, Lumb GA, Nicholson WF. Elective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet. 1960; 1(7128):793–799.

7. Zedenius J, Wadstrom C, Delbridge L. Routine autotransplantation of at least one parathyroid gland during total thyroidectomy may reduce permanent hypoparathyroidism to zero. Aust N Z J Surg. 1999; 69(11):794–797.

8. Richards ML, Wormuth J, Bingener J, Sirinek K. Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management? Surgery. 2006; 139(2):174–180.

9. Hibi Y, Tominaga Y, Sato T, Katayama A, Haba T, Uchida K, et al. Reoperation for renal hyperparathyroidism. World J Surg. 2002; 26(10):1301–1307.

10. Choi Y-S, Lee KE, Koo DH, Oh EM, Choi JY, Park K-w, et al. The postoperative outcomes of patients with primary, secondary and tertiary hyperparathyroidism : 14 year experience of Seoul National University Hospital. Korean J Clin Oncol. 2011; 7(1):52–59.

11. Boggs JE, Irvin GL 3rd, Molinari AS, Deriso GT. Intraoperative parathyroid hormone monitoring as an adjunct to parathyroidectomy. Surgery. 1996; 120(6):954–958.

12. Borot S, Lapierre V, Carnaille B, Goudet P, Penfornis A. Results of cryopreserved parathyroid autografts: a retrospective multicenter study. Surgery. 2010; 147(4):529–535.